18 Nov 2024
// PR NEWSWIRE
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 3ASENAPINE MALEATE
02 2ASPIRIN; BUTALBITAL; CAFFEINE
03 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
04 2BRIMONIDINE TARTRATE
05 2CHLORAMPHENICOL
06 1CHLORAMPHENICOL; PREDNISOLONE
07 1CROMOLYN SODIUM
08 1CYCLOSPORINE
09 1DEXAMETHASONE
10 2DICYCLOMINE HYDROCHLORIDE
11 3DILTIAZEM HYDROCHLORIDE
12 1DIPIVEFRIN HYDROCHLORIDE
13 1EPINASTINE HYDROCHLORIDE
14 1ESTRADIOL
15 4ETHINYL ESTRADIOL; NORETHINDRONE
16 1ETHOXZOLAMIDE
17 1FERRIC OXYHYDROXIDE
18 4FLUOCINOLONE ACETONIDE
19 1FLUOROMETHOLONE
20 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
21 1FLURBIPROFEN SODIUM
22 1GATIFLOXACIN
23 1GENTAMICIN SULFATE
24 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
25 5HYDROCORTISONE
26 2HYDROXYPROGESTERONE CAPROATE
27 1IDOXURIDINE
28 1KETOROLAC TROMETHAMINE
29 2LEVOBUNOLOL HYDROCHLORIDE
30 6LIOTRIX (T4;T3)
31 1MEDRYSONE
32 1MEMANTINE HYDROCHLORIDE
33 12MORPHINE SULFATE
34 1NAPHAZOLINE HYDROCHLORIDE
35 4NEBIVOLOL HYDROCHLORIDE
36 1NEDOCROMIL SODIUM
37 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
38 1OFLOXACIN
39 2OXYBUTYNIN
40 5OnabotulinumtoxinA
41 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
42 1PODOFILOX
43 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
44 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
45 2PROGESTERONE
46 1PROPARACAINE HYDROCHLORIDE
47 1SELENIUM SULFIDE
48 3SULFACETAMIDE SODIUM
49 5TAZAROTENE
50 2TRETINOIN
51 1TRIAMCINOLONE ACETONIDE
52 3TRIMEPRAZINE TARTRATE
53 2TROSPIUM CHLORIDE
54 2URSODIOL
01 2AEROSOL;TOPICAL
02 17CAPSULE, EXTENDED RELEASE;ORAL
03 3CAPSULE;ORAL
04 7CREAM;TOPICAL
05 1CREAM;VAGINAL
06 1EMULSION; OPHTHALMIC
07 1FILM, EXTENDED RELEASE;TRANSDERMAL
08 1GEL, METERED;TRANSDERMAL
09 5GEL;TOPICAL
10 2GEL;VAGINAL
11 3INJECTABLE;INJECTION
12 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
13 1LOTION/SHAMPOO;TOPICAL
14 6OINTMENT;OPHTHALMIC
15 2OINTMENT;TOPICAL
16 21SOLUTION/DROPS;OPHTHALMIC
17 1SOLUTION;ORAL
18 2SOLUTION;TOPICAL
19 3SUSPENSION/DROPS;OPHTHALMIC
20 2SUSPENSION;OPHTHALMIC
21 1SYRUP;ORAL
22 17TABLET;ORAL
23 2TABLET;ORAL-21
24 2TABLET;ORAL-28
25 3TABLET;SUBLINGUAL
26 5VIAL; SINGLE-USE
01 20.01%
02 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.0125MG;0.0031MG
04 30.025%
05 10.025MG;0.0063MG
06 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 20.035MG;0.5MG
08 20.035MG;1MG
09 10.0375%
10 30.05%
11 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 10.05MG;0.0125MG
13 10.075%
14 60.1%
15 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 10.1%;10%
17 10.12%;0.1%
18 10.15MG;0.0375MG
19 10.1MG;0.025MG
20 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 20.2%;10%
22 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 10.25MG;0.0625MG
24 20.3%
25 60.5%
26 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 51%
28 11%;0.5%
29 210%
30 110,000 UNITS/ML;EQ 1MG BASE/ML
31 2100 UNITS/VIAL
32 1100MG
33 110MG
34 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 1125MG
37 1125MG/ML
38 1130MG
39 1150MG
40 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 22.5%
43 1200 UNITS/VIAL
44 1200MG
45 120MG
46 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1250MG
49 1250MG/ML
50 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 13%
52 13.9MG/24HR
53 130%
54 130MG
55 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1325MG;50MG;40MG;30MG
57 14%
58 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
59 140MG
60 250 UNITS/VIAL
61 1500MG
62 150MG
63 160MG
64 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 170MG
66 18%
67 180MG
68 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
69 1EQ 0.3% BASE
70 1EQ 0.3% BASE;0.6%
71 1EQ 0.3% BASE;1%
72 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
73 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
74 2EQ 10MG BASE
75 3EQ 2.5MG BASE
76 1EQ 2.5MG BASE/5ML
77 1EQ 20MG BASE
78 3EQ 5MG BASE
01 84DISCN
02 22RX
03 6Blank
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : CHLOROPTIC S.O.P.
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 61187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?